Remove Dosage Remove Events Remove Labelling
article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

The Indian Pharmaceutical Alliance (IPA) questions the reliance on the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) in the Ohio State University report titled, Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events.

article thumbnail

Off-label Use

RX Note

In fact, off-label drug uses can become widely entrenched in clinical practice and become predominant treatments for a given clinical condition. In a study published in JAMA Internal Medicine , off-label use lacking strong scientific evidence had a higher adverse drug event rate compared with on-label use.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sandoz granted novel biosimilars approval

European Pharmaceutical Review

Keren Haruvi, President Sandoz North America highlighted that denosumab is a medicine that can address primary and secondary bone loss, such as osteoporosis, as well as cancer-related skeletal events. The approval is also accompanied by labelling with safety warnings. Wyost Similarly, Wyost 120 mg/1.7

article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

These drugs have been rigorously tested by regulatory bodies around the world before they’re made available to ensure they work as labelled, but despite that, adverse events crop up. Looking at an individual’s genomic profile also provides an understanding of appropriate medication dosage. billion in the United States alone.

Dosage 98
article thumbnail

Promising schizophrenia drug faces tough competition

European Pharmaceutical Review

If approved, paliperidone palmitate extended-release injectable suspension (LY03010) is primed as a favourable option to treat schizophrenia, due to reduced dosage requirement of a once-a-month, yet it risks being hidden in a crowded long-acting injectable (LAI) market, GlobalData warns.

Dosage 105
article thumbnail

The IMA Group at ACHEMA 2024 : All-In-One solutions for the pharmaceutical sector

European Pharmaceutical Review

The ADAPTA 50 capsule filler features innovative technical solutions to manage complex solid dosage forms such as product combination in hard gelatine capsules or powder micro-dosing for Dry Powder Inhalers. customers will have the opportunity to experience first hand various digital solutions aimed at reducing maintenance costs and downtime.

article thumbnail

Panel Discussion: Patient-centric packaging: Safe, Smart, Secure

Express Pharma

This is key to achieving desired healthcare outcomes [2] Bane areas such as inaccessibility, labelling errors, dosage errors, and counterfeit drugs, must be addressed to make pharma packaging more patient-centric [3] One solution fits all is not the right approach.